First Command Advisory Services Inc. lifted its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 8.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,489 shares of the company’s stock after purchasing an additional 514 shares during the period. First Command Advisory Services Inc.’s holdings in Colgate-Palmolive were worth $590,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the business. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth about $27,000. Union Bancaire Privee UBP SA acquired a new stake in Colgate-Palmolive in the 4th quarter worth approximately $32,000. Hager Investment Management Services LLC acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $42,000. Finally, Roxbury Financial LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $43,000. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Performance
CL stock opened at $90.17 on Thursday. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm has a market cap of $73.18 billion, a PE ratio of 25.62, a P/E/G ratio of 4.20 and a beta of 0.44. The business’s 50-day moving average price is $88.81 and its two-hundred day moving average price is $95.62.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 56.82%.
Wall Street Analysts Forecast Growth
CL has been the topic of a number of recent analyst reports. Raymond James reiterated an “outperform” rating and issued a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Stifel Nicolaus cut their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. Barclays lowered their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Finally, Piper Sandler reduced their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus target price of $101.16.
Get Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
- Five stocks we like better than Colgate-Palmolive
- 3 Dividend Kings To Consider
- Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Axon: Long-Term Outlook Is Strong Despite Federal Budget Worries
- Trading Halts Explained
- 3 Stocks Powering the Future of Autonomous Driving
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.